Search
for
Sort by
Research 91–120 of 95
- An Advanced Review: Polyurethane-Related Dressings for Skin Wound Repair
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Medicinal and cosmetic products used in treatment of hair loss
- EGFR Controls Hair Shaft Differentiation in a p53-Independent Manner
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Cutaneous Lymphadenoma Is a Distinct Trichoblastoma-like Lymphoepithelial Tumor With Diffuse Androgen Receptor Immunoreactivity, Notch1 Ligand in Reed-Sternberg–like Cells, and Common EGFR Somatic Mutations
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Dermatologic Reactions to Targeted Therapy
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Skin reactions caused by epidermal growth factor receptor inhibitors and their management
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- 증례 : Gefitinib에 의해 유발된 반흔성 탈모증
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- Directed Expression of Keratin 16 to the Progenitor Basal Cells of Transgenic Mouse Skin Delays Skin Maturation
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series